Table of Content

Open Access iconOpen Access

ARTICLE

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma

by

* Department of Pathology, Division of Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
† Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
‡ Department of Pathology, Division of Cytopathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
§ Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA

Oncology Research 2015, 23(3), 137-146. https://doi.org/10.3727/096504015X14500972666761

Abstract

“Double” or “triple” hit lymphomas (D/THL) with recurrent translocations involving MYC/8q24 and BCL2/18q21 and/or BCL6/3q27 are characterized by a poor prognosis, but their identification is hampered by the clinicopathologic overlap with other disease categories. Cases with circulating blastic-appearing cells may initially cause concern for lymphoblastic leukemia a diagnostic dilemma, which has not been well studied. There is only limited literature regarding the flow cytometric (FC) D/THL phenotype and its clinical correlates. The FC features of 20 D/THL (11 BCL2+/MYC+, 5 BCL6+/MYC+, 4 BCL2+/BCL6+/MYC+) were evaluated, compared to 20 B-lymphoblastic leukemias (B-LBL), and correlated with overall survival. Most (89%, 17/19) D/THL were CD10+ , 47% (9/19) lacked surface light chain, and a significant subset underexpressed CD45 (47%, 9/19), CD20 (42% 8/19), and/or CD19 (39%, 7/18), which did not vary by genetic subgroup. Compared to B-LBL, D/THL less frequently underexpressed CD45 (p=0.0001) and CD20 (p=0.0004). Lower levels of BCL2 expression were noted in the BCL6+/MYC+ and BCL2+/BCL6+/MYC+ subgroups versus BCL2+/MYC+ cases (p=0.0014). Of the flow cytometric parameters assessed, dim CD45 expression correlated with inferior survival (p=0.01). Although there is some overlap with B-LBL, D/THL demonstrates a characteristic immunophenotype which may have prognostic significance and warrants further investigation.

Keywords


Cite This Article

APA Style
Roth, C.G., Gillespie-Twardy, A., Marks, S., Agha, M., Raptis, A. et al. (2015). Flow cytometric evaluation of double/triple hit lymphoma. Oncology Research, 23(3), 137-146. https://doi.org/10.3727/096504015X14500972666761
Vancouver Style
Roth CG, Gillespie-Twardy A, Marks S, Agha M, Raptis A, Hou J, et al. Flow cytometric evaluation of double/triple hit lymphoma. Oncol Res. 2015;23(3):137-146 https://doi.org/10.3727/096504015X14500972666761
IEEE Style
C.G. Roth et al., “Flow Cytometric Evaluation of Double/Triple Hit Lymphoma,” Oncol. Res., vol. 23, no. 3, pp. 137-146, 2015. https://doi.org/10.3727/096504015X14500972666761



cc Copyright © 2015 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 148

    View

  • 87

    Download

  • 0

    Like

Share Link